Daiichi Sankyo (India)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
62%
Total
Publications
309
Total Open
Publications
192
Total
Citations
3.1K
Open Access
Percentage
62%
Total
Publications
309
Total Open
Publications
192
Total
Citations
3.1K
Breakdown
Publisher Open
53%
Both
6%
Other Platform Open
3%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 9%
16
Hybrid 12%
23
No Guarantees 79%
144
Other Platform Open
Domain 75%
21
Public 18%
5
Preprint 11%
3
Institution 7%
2
Other Internet 7%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 21 |
Europe PMC | Domain | 18 |
Semantic Scholar | Public | 5 |
bioRxiv | Preprint | 3 |
Aalborg Universitet - VBN Forskningsportal | Other Internet | 2 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
Kyushu University - QIR (Kyushu University Institutional Repository) | Institution | 1 |
INFN Catania - INFM-OAR | Other Internet | 1 |